Influence of dual antiplatelet therapy on mean platelet volume in patients with coronary artery disease undergoing percutaneous coronary intervention

Heart and Vessels

Volumn 31, Issue 3, 2016, Pages 269-274

  Higaki, Tadanao ^a   Kurisu, Satoshi ^a   Watanabe, Noriaki ^a   Ikenaga, Hiroki ^a   Shimonaga, Takashi ^a   Iwasaki, Toshitaka ^a   Mitsuba, Naoya ^a   Ishibashi, Ken ^a   Dohi, Yoshihiro ^a   Fukuda, Yukihiro ^a   Kihara, Yasuki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Coronary artery disease; Dual antiplatelet therapy; Mean platelet volume

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; HEMOGLOBIN; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ARTICLE; BLOOD EXAMINATION; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; MALE; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PRIORITY JOURNAL; STENT THROMBOSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; TREADMILL EXERCISE; ADVERSE EFFECTS; AGED; ANALOGS AND DERIVATIVES; BLOOD; COMBINATION DRUG THERAPY; DEVICES; DRUG EFFECTS; DRUG MONITORING; FEMALE; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY; RETROSPECTIVE STUDY; THROMBOCYTE; TIME FACTOR; TREATMENT OUTCOME;

AGED; ASPIRIN; BLOOD PLATELETS; CORONARY ARTERY DISEASE; DRUG MONITORING; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MEAN PLATELET VOLUME; PERCUTANEOUS CORONARY INTERVENTION; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84959542244     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-014-0599-z     Document Type: Article

References (30)

1. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox KA, Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358:527–533
2. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288:2411–2420
3. Anzai A, Maekawa Y, Kodaira M, Mogi S, Arai T, Kawakami T, Kanazawa H, Hayashida K, Yuasa S, Kawamura A, Fukuda K (2014) Prognostic implications of optimal medical therapy in patients undergoing percutaneous coronary intervention for acute coronary syndrome in octogenarians. Heart Vessels. doi:10.1007/s00380-014-0474-y
4. Campo G, Fileti L, de Cesare N, Meliga E, Furgieri A, Russo F, Colangelo S, Brugaletta S, Ferrari R, Valgimigli M (2010) Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy. J Am Coll Cardiol 56:1447–1455
5. Cameron HA, Phillips R, Ibbotson RM, Carson PH (1983) Platelet size in myocardial infarction. Br Med J (Clin Res Ed) 287:449–451
6. Yarlioglues M, Kaya MG, Ardic I, Dogdu O, Kasapkara HA, Gunturk E, Akpek M, Kalay N, Dogan A, Ozdogru I, Oguzhan A (2011) Relationship between mean platelet volume levels and subclinical target organ damage in newly diagnosed hypertensive patients. Blood Press 20:92–97
7. Pizzulli L, Yang A, Martin JF, Luderitz B (1998) Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart 19:80–84
8. Vizioli L, Muscari S, Muscari A (2009) The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract 63:1509–1515
9. Shah B, Oberweis B, Tummala L, Amoroso NS, Lobach I, Sedlis SP, Grossi E, Berger JS (2013) Mean platelet volume and long-term mortality in patients undergoing percutaneous coronary intervention. Am J Cardiol 111:185–189
10. Sun X, Jia Z (2012) A brief review of biomarkers for preventing and treating cardiovascular diseases. J Cardiovasc Dis Res 3:251–254
11. De Luca G, Santagostino M, Secco GG, Cassetti E, Giuliani L, Franchi E, Coppo L, Iorio S, Venegoni L, Rondano E, Dell’Era G, Rizzo C, Pergolini P, Monaco F, Bellomo G, Marino P (2009) Mean platelet volume and the extent of coronary artery disease: results from a large prospective study. Atherosclerosis 206:292–297
12. Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, Sunder-Plassmann R (2002) Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 117:399–404
13. Kario K, Matsuo T, Nakao K (1992) Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clin Lab Haematol 14:281–287
14. Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, Lakasas G (2004) Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 15:475–478
15. Coban E, Ozdogan M, Yazicioglu G, Akcit F (2005) The mean platelet volume in patients with obesity. Int J Clin Pract 59:981–982
16. Pathansali R, Smith N, Bath P (2001) Altered megakaryocyte-platelet haemostatic axis in hypercholesterolaemia. Platelets 12:292–297
17. Savi P, Herbert JM (2005) Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. Semin Thromb Hemost 31:174–183
18. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE, SIRIUS Investigators (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315–1323
19. Erhart S, Beer JH, Reinhart WH (1999) Influence of aspirin on platelet count and volume in humans. Acta Haematol 101:140–144
20. Colkesen Y, Coskun I, Muderrisoglu H (2013) The effect of aspirin on mean platelet volume in patients with paroxysmal atrial fibrillation. Platelets 24:263–266
21. Guthikonda S, Alviar CL, Vaduganathan M, Arikan M, Tellez A, DeLao T, Granada JF, Dong JF, Kleiman NS, Lev EI (2008) Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 52:743–749
22. De Luca G, Secco GG, Iorio S, Verdoia M, Bellomo G, Marino P (2012) Short-term effects of aspirin and clopidogrel on mean platelet volume among patients with acute coronary syndromes. A single-center prospective study. Blood Coagul Fibrinolysis 23:756–759
23. Le Breton H, Plow EF, Topol EJ (1996) Role of platelets in restenosis after percutaneous coronary revascularization. J Am Coll Cardiol 28:1643–1651
24. Yang A, Pizzulli L, Luderitz B (2006) Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris. Thromb Res 117:371–377
25. Avci A, Boyaci A, Cagli K, Cosgun A, Gokce V, Duru E, Korkmaz S (2004) Influence of haematological parameters before coronary angioplasty on subsequent restenosis. Acta Cardiol 59:263–268
26. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS (2010) Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 8:148–156
27. Kaiser C, Galatius S, Erne P, Eberli F, Alber H, Rickli H, Pedrazzini G, Hornig B, Bertel O, Bonetti P, De Servi S, Brunner-La Rocca HP, Ricard I, Pfisterer M, BASKET–PROVE Study Group (2010) Drug-eluting versus bare-metal stents in large coronary arteries. N Engl J Med 363:2310–2319
28. Lunder M, Ziberna L, Janić M, Jerin A, Skitek M, Sabovič M, Drevenšek G (2013) Low-dose atorvastatin, losartan, and particularly their combination, provide cardiovascular protection in isolated rat heart and aorta. Heart Vessels 28:246–254
29. Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Kano H, Uejima T, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T (2014) Effects of statin treatment in patients with coronary artery disease and chronic kidney disease. Heart Vessels 29:21–28
30. Sivri N, Tekin G, Yalta K, Aksoy Y, Senen K, Yetkin E (2013) Statins decrease mean platelet volume irrespective of cholesterol lowering effect. Kardiol Pol 10:1042–1047